Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: TOPIC Trial for COPD [EARLY_Phase 1]
Phase 1 TOPIC Trial for chronic obstructive pulmonary disease completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: The Occurence of Inflammation and Oxidative Stress in Lung Diseases
A completed clinical trial evaluated the occurrence of inflammation and oxidative stress in multiple lung diseases. The conditions studied i…
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: CAN BREATHE in COPD Trial [Phase 2]
This clinical trial update notes a Phase 2 COPD study called CAN BREATHE, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease [NA]
This entry reports the completion of a clinical trial evaluating mindfulness-based cognitive therapy for chronic obstructive pulmonary disea…
-
FDA approval · 2017-02-15FDA Approved: SPIRIVA RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Spiriva Respimat (tiotropium bromide inhalation spray) from Boehringer Ingelheim Pharmaceuti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination [Phase 3]
Phase 3 trial update reporting long-term efficacy and safety data for the aclidinium bromide/formoterol fumarate fixed-dose combination in c…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events
This clinical trial update reports results on the use of combined bronchodilators in chronic obstructive pulmonary disease and the associate…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease [Phase 2]
This ClinicalTrials.gov entry reports a Phase 2 trial evaluating cholecalciferol (vitamin D3) supplementation to strengthen inspiratory musc…
-
CLINICAL_TRIALS withdrawal · 2017-02-15Clinical Trial Update: Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD [Phase 3]
A Phase 3 trial comparing Formoterol/Fluticasone and Salmeterol/Fluticasone for moderate-to-severe chronic obstructive pulmonary disease was…
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD [NA]
Clinical trial update about a study evaluating pulmonary rehabilitation, dyspnea measures, and walk/step testing in chronic obstructive pulm…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs [NA]
A completed clinical trial evaluating the impact and costs of patient education for individuals with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Social Work Intervention Focused on Transitions [NA]
Clinical trial update for a social work–driven care transitions intervention to reduce 30-day rehospitalizations among at-risk older adults;…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects [Phase 4]
Phase 4 study evaluating ease of use and correct use of the placebo Ellipta inhaler in adults with chronic obstructive pulmonary disease; re…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3) [Phase 3]
This is a completed Phase 3 PINNACLE 3 extension study evaluating PT003, PT001, and PT005 in moderate to very severe COPD, with results post…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Nitrate Supplementation in Chronic Obstructive Pulmonary Disease (COPD) [NA]
The document reports that a clinical trial evaluating nitrate supplementation for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients [Phase 2]
A Phase 2 clinical trial update on doses of GSK961081, studied first in healthy volunteers and then in COPD patients, with the study status …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation [NA]
A completed clinical trial evaluated the deposition of aerosolized drugs during mechanical ventilation in patients with chronic obstructive …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV
This completed trial evaluated FiO2 in COPD patients treated with normobaric oxygen versus noninvasive ventilation in a home-care setting.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Seasonal Trends in Pneumococcal Carriage in COPD Patients
The study completed and reported on seasonal patterns of pneumococcal carriage in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: PT003 MDI Cardiovascular Safety Study [Phase 2]
Phase 2 cardiovascular safety study of PT003 MDI in chronic obstructive pulmonary disease has completed and results have been posted.
-
EMA withdrawal · 2017-01-31EMA Withdrawn: Budesonide/Formoterol Teva (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
EMA confirms withdrawal of Budesonide/Formoterol Teva, a combination inhaled therapy, from the product market.
-
FDA approval · 2017-01-31FDA Approved: LEVALBUTEROL — Original Application (Aurobindo Pharma Limited)
The FDA approved an original ANDA for Levalbuterol from Aurobindo Pharma Limited, providing a generic option for this bronchodilator.
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients [NA]
The document reports the completed clinical trial evaluating the safety, tolerability, and efficacy of an oral nutritional supplement in pat…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial evaluating the effects of a pulmonary rehabilitation program on exercise capacity and quality of life in patients…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Comparison of 3-Minute Step Test (3MStepT) and 6-Minute Walk Test (6MWT) in COPD Patients
This clinical trial update reports a completed study comparing the 3-Minute Step Test and the 6-Minute Walk Test in patients with COPD to ev…